Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rafael O. Trevisan"'
Autor:
YAGO MARCOS PESSOA-GONÇALVES, ANA LUCIA G. DE JESUS, HENRIQUE C.P. CARVALHO, CHAMBERTTAN S. DESIDÉRIO, RAFAEL O. TREVISAN, WESLLEY G. BOVI, MARCOS VINÍCIUS DA SILVA, CARLO JOSÉ F. OLIVEIRA
Publikováno v:
Anais da Academia Brasileira de Ciências, Vol 96, Iss 3 (2024)
Abstract Between 2017 and 2021, the Brazilian Unified Health System (BUHS) administered a total of 527,903,302 doses of immunizations. Each immunization results in the presence of a residual volume (RV) due to syringe dead space (DS). The Internation
Externí odkaz:
https://doaj.org/article/a249a64644a742089bb27d29f1ae630b
Autor:
Alice P. Borges, Malu M. S. Obata, Silvia H. Libardi, Rafael O. Trevisan, Victor M. Deflon, Ulrich Abram, Francis B. Ferreira, Luiz Antônio S. Costa, Antonio O. T. Patrocínio, Marcos V. da Silva, Júlio C. Borges, Pedro I. S. Maia
Publikováno v:
Pharmaceutics, Vol 16, Iss 4, p 452 (2024)
Leishmaniasis is a group of parasitic diseases with the potential to infect more than 1 billion people; however, its treatment is still old and inadequate. In order to contribute to changing this view, this work consisted of the development of comple
Externí odkaz:
https://doaj.org/article/ea751c10cb2546d0868d017ad900d1b8
Autor:
Bruna Raphaela Oliveira Silva, Wellington Francisco Rodrigues, Daniela Gomes Pires Abadia, Djalma A. Alves da Silva, Leonardo E. Andrade e Silva, Chamberttan S. Desidério, Thais Soares Farnesi-de-Assunção, Juliana C. Costa-Madeira, Rafaela M. Barbosa, Anna V. Bernardes e Borges, Andrezza C. C. Hortolani Cunha, Loren Q. Pereira, Fernanda R. Helmo, Marcela Rezende Lemes, Laís M. Barbosa, Rafael O. Trevisan, Malu Mateus Santos Obata, Giovanna F. Bueno, Fabiano V. Mundim, Ana Carolina M. Oliveira-Scussel, Ivan B. Monteiro, Yulsef M. Ferreira, Guilherme H. Machado, Kennio Ferreira-Paim, Hélio Moraes-Souza, Marcos Vinicius da Silva, Virmondes Rodrigues Júnior, Carlo José Freire Oliveira
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
COVID-19, also known as coronavirus disease 2019, is an infectious viral disease caused by SARS-CoV-2, a novel coronavirus. Since its emergence, its epidemiology has been explored; however, for some regions of the world, COVID-19’s behavior, incide
Externí odkaz:
https://doaj.org/article/ca769b4a368e4672b4e12414b39f29cd
Autor:
Anna Glória Fonseca Teodoro, Wellington Francisco Rodrigues, Thais Soares Farnesi-de-Assunção, Anna V. Bernardes e Borges, Malu Mateus Santos Obata, José Rodrigues do Carmo Neto, Djalma A. Alves da Silva, Leonardo E. Andrade-Silva, Chamberttan S. Desidério, Juliana C. Costa-Madeira, Rafaela M. Barbosa, Andrezza C. C. Hortolani Cunha, Loren Q. Pereira, Fernanda Bernadelli de Vito, Sarah Cristina Sato Vaz Tanaka, Fernanda R. Helmo, Marcela Rezende Lemes, Laís M. Barbosa, Rafael O. Trevisan, Fabiano V. Mundim, Ana Carolina M. Oliveira-Scussel, Paulo Roberto Resende Junior, Ivan B. Monteiro, Yulsef M. Ferreira, Guilherme H. Machado, Kennio Ferreira-Paim, Hélio Moraes-Souza, Carlo José Freire de Oliveira, Virmondes Rodrigues Júnior, Marcos Vinicius da Silva
Publikováno v:
Viruses, Vol 15, Iss 4, p 938 (2023)
SARS-CoV-2 (COVID-19) infection is responsible for causing a disease with a wide spectrum of clinical presentations. Predisposition to thromboembolic disease due to excessive inflammation is also attributed to the disease. The objective of this study
Externí odkaz:
https://doaj.org/article/ce131f97c6cb4cec8574c1b91d0d1402